The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
Open accessAbstract
BACKGROUND: Human immunodeficiency virus (HIV) replication and immune activation may increase inflammation and coagulation biomarkers. Limited data exist comparing such biomarkers in persons with and without HIV infection. METHODS: For persons 45-76 years of age, levels of high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-6, D-dimer, and cystatin C were compared in 494 HIV-infected individuals in the Strategies for Management of Anti-Retroviral Therapy (SMART) study and 5386 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) study. For persons 33-44 years of age, hsCRP and IL-6 levels were compared in 287 participants in the SMART study and 3231 participants in the Coronary Artery Development in Young Adults (CARDIA) study. RESULTS: hsCRP and IL-6 levels were 55% (P < . 001) and 62 (P < . 001) higher among HIV-infected participants than among CARDIA study participants. Compared with levels noted in MESA study participants, hsCRP, IL-6, D-dimer, and cystatin C levels were 50%, 152%, 94%, and 27% higher, respectively (P < . 001, for each), among HIV-infected participants. HIV-infected participants receiving antiretroviral therapy who had HIV RNA levels 400 copies/mL had levels higher (by 21% to 60%) (P < . 001) than those in the general population, for all biomarkers. CONCLUSIONS: hsCRP, IL-6, D-dimer, and cystatin C levels are elevated in persons with HIV infection and remain so even after HIV RNA levels are suppressed with antiretroviral therapy. Additional research is needed on the pathophysiology of HIV-induced activation of inflammatory and coagulation pathways, to guide potential interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, this therapy does not protect patients from the persistent immune activation, chronic inflammation, and excess risk of developing CVD and frailty131–135.”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [132]
In the citing paper
“Many (but not all) biomarkers associated with inflammation (e.g., IL-6, sCD14) and end-organ diseases common in seniors (e.g., cystatin C as a marker of declining renal function) are higher in antiretroviral-treated adults than uninfected adults (50).”
From HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group (2012) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citationC-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 4,694
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
Bild, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf113 · Cited by 3,942
CD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Self-citationAssociations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Self-citationCystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons
Shlipak, M. G., Sarnak, M. J., Katz, R., Fried, L. F., Seliger, S. L., Newman, A. B., Siscovick, D. S., & Stehman‐Breen, C. O. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043161 · Cited by 1,241
Self-citationRelation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098
Self-citationMacy, E. M., Hayes, T. E., & Tracy, R. P. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.1.52 · Cited by 797
Self-citation
Cited by
Sorted by citations
Items 701–800 of 870
Tailoring cardiovascular risk prediction for people living with HIV: Evidence from Malaysia
Hwong, W. Y., Teh, H. S., Yang, S. L., Lee, J. L., Anand, S., Sim, B. L. H., Lim, Y. M. F., & Tay, K. H. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.108211 · Cited by 1
Rallón, N. I., Restrepo, C., Manquillo, A., Pérez‐Sánchez, C., Mahillo, I., Nistal, S., Al‐Hayani, A., Cabello, A., Carrillo-Acosta, I., Prieto, L., et al. (2026) · Journal of Medical Virology · doi:10.1002/jmv.70901 · Cited by 1
Tenofovir, Interferon Pathways, and Mucosal Immunity: Implications for People Living With HIV
Hladik, F., Hughes, S. M., Levy, C., Creighton, R. L., Mackelprang, R. D., & Gornalusse, G. G. (2026) · American Journal of Reproductive Immunology · doi:10.1111/aji.70255 · Cited by 1
Monocyte Dll4 Contributes to Systemic Inflammation in People Living With HIV
Wang, S., Singh, M. V., Morrell, C. N., Yang, H., Rhen, J. M., Wang, T., Mohamad, L. A., Xu, J. J., Nguyen, T., Ture, S. K., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.326836 · Cited by 5
Nagao, A., Sawada, A., Kanematsu, T., Yamasaki, N., Takedani, H., Nojima, M., Hiroi, Y., Fujii, T., Suzuki, N., Matsushita, T., et al. (2026) · Blood Advances · doi:10.1182/bloodadvances.2026020490 · Cited by 1
Grant, P., Sheikh, V., DerSimonian, R., Rupert, A. W., Roby, G. A., Pau, A. K., Sneller, M. C., Rico, S.-V., Brown, T. T., & Sereti, I. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0028 · Cited by 1
Achhra, A. C., Amin, J., Law, M. G., Grulich, A. E., Yeung, J. Y. K., Kelleher, A. D., Cooper, D. A., & the Health In Men study group (2012) · Antiviral Therapy · doi:10.3851/imp2434 · Cited by 1
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodystrophy
Guaraldi, G., Stentarelli, C., & Faluz, J. (2013) · Clinical Investigation · doi:10.4155/cli.13.66 · Cited by 1
Pinnetti, C., Bandera, A., Mangioni, D., & Gori, A. (2012) · Future Virology · doi:10.2217/fvl.12.80 · Cited by 1
Deeks, S. G., Gandhi, R. T., Chae, C. U., & Lewandrowski, K. B. (2012) · New England Journal of Medicine · doi:10.1056/nejmcpc1200090 · Cited by 1
Trastornos neuropsiquiátricos en la población con VIH: una revisión narrativa
Salazar, L. M., la Hoz, A. D., Gaviria, R. R., Valderrama, S., & Gómez–Restrepo, C. (2017) · Universitas Médica · doi:10.11144/javeriana.umed58-1.tnpv · Cited by 1
Cystatin-C in HIV-infected obese individuals
Çağlayık, D. Y., Arikan, I. H., & Çeçen, S. (2019) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2019.43650 · Cited by 1
How Feasible Is Renal Transplantation in HIV-Infected Patients?
Ailioaie, O. R., & Mircescu, G. (2017) · Europe PMC (PubMed Central) · Cited by 1
Challenges to Advanced Nursing Practice in Nigeria, Possible Ways Forward
Nchekwubedi, C. S. (2020) · South Asian Research Journal of Nursing and Healthcare · doi:10.36346/sarjaf.2020.v02i04.003 · Cited by 1
Weil’s Disease in an HIV-Infected Patient
Nguyen, D. B., Chaparala, S., Morel, L., Bueno, Y., & Lovell, R. D. (2021) · Cureus · doi:10.7759/cureus.14241 · Cited by 1
Fourman, L. T., Mueller, S. B., Boutin, A., Zheng, I., Pan, C. S., Gerard, M. E., Stanley, T. L., & Roberts, D. J. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002734 · Cited by 1
Lin, T., Lin, F., Hung, C.-C., Liu, C., Hsiao, Y.-C., Lee, C.-H., & Wang, N. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.05.001 · Cited by 1
(2014) · Microbiology Australia · doi:10.1071/mav35n2 · Cited by 1
Schapkaitz, E., Libhaber, E. N., Jacobson, B. F., Toman, M., Gerber, A., & Buller, H. R. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2022.07.001 · Cited by 1
Effect of aging on immune cells in male HIV-infected and -uninfected healthy individuals
Rai, M. A., Shi, V., Kennedy, B. D., Whitehead, E. J., Justement, J. S., Paul, S., Blažková, J., & Chun, T. (2022) · AIDS · doi:10.1097/qad.0000000000003331 · Cited by 1
Bhoelan, S., Howard, J. B., Tichelaar, V., Bierman, W. F. W., & Meijer, K. (2023) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296231165492 · Cited by 1
Hartigan-O’Connor, D. J., & Brander, C. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780197679098.003.0006 · Cited by 1
Ni, W., Kong, H., Han, L., Chen, Y., Bai, J., & Liu, Y. (2023) · Journal of the Association of Nurses in AIDS Care · doi:10.1097/jnc.0000000000000438 · Cited by 1
Impacto presupuestario del tratamiento antirretroviral. Reflexión desde las guías de GESIDA
Grupo de trabajo de la Cohorte, V. A. C. H. (2012) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2012.01.015 · Cited by 1
Cioe, P. A. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/585p-sn47 · Cited by 1
Moyle, G. J., Hardy, H., Uy, J. P., Ray, N., Jiménez‐Expósito, M. J., McGrath, D., & DeJesus, E. (2013) · Antiviral Therapy · doi:10.3851/imp2778 · Cited by 1
Leaky gut, clotting, and vasculopathy in SIV
Hunt, P. W. (2012) · Blood · doi:10.1182/blood-2012-06-435115 · Cited by 1
A Review of Human Immunodeficiency Virus on the Auditory System
Torre, P. (2015) · Perspectives on Hearing and Hearing Disorders Research and Diagnostics · doi:10.1044/hhd19.2.55 · Cited by 1
Case 30-2012: A 54-Year-Old Woman with HIV Infection, Dyspnea, and Chest Pain
Cabot, R. C., Harris, N. L., Rosenberg, E. S., Shepard, J.-A. O., Cort, A. M., Ebeling, S. H., McDonald, E. K., & Francis, S. (2012) · Cited by 1
Gannon, P. J. (2014) · Scholarly Commons (University of Pennsylvania) · Cited by 1
CLINICAL AND DIAGNOSTIC VALUE OF ASSESSMENT OF SYSTEMIC INFLAMMATION IN PATIENTS WITH HIV INFECTION
Matuzkova, A., Pshenichnaya, N. Y., Георгиевич, С. А., Dosyagaeva, L., Tverdokhlebova, T. I., & Iagovkin, E. A. (2018) · HIV Infection and Immunosuppressive Disorders · doi:10.22328/2077-9828-2018-10-3-64-71 · Cited by 1
Venous Thromboembolic Disease and Hypercoagulability in Human Immunodeficiency Virus Infection
Bender, M. T., & O’Beirne, S. L. (2019) · Springer eBooks · doi:10.1007/978-3-030-10451-1_14 · Cited by 1
Dold, L., Zimmer, L., Schwarze‐Zander, C., Boesecke, C., Mohr, R. U., Wasmuth, J. ‐., Ommer, K., Gathof, B. S., Krämer, B., Nattermann, J., et al. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01996-7 · Cited by 1
Daharsh, L., Ramer‐Tait, A. E., & Li, Q. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.16.993956 · Cited by 1
Villar, S. S., López‐Huertas, M. R., Jiménez, D., Galera, C., Martínez‐Sanz, J., Moreno, E., Muriel, A., Gutiérrez, F., Busca, C., Portilla, J., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3976877 · Cited by 1
Villar, S. S., & Moreno, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923905 · Cited by 1
Williams, J. P., Fidler, S. J., & Frater, J. (2011) · InTech eBooks · doi:10.5772/22942
Martínez, E. (2013) · Revista Clínica Española · doi:10.1016/j.rce.2013.03.012
Albini, L., Focà, E., Motta, D., Gotti, D., Lapadula, G., Cesana, B. M., & Torti, C. (2011) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2011.0243
¿Es la infección por el virus de la inmunodeficiencia humana una enfermedad inflamatoria?
Gutiérrez, F., & Masiá, M. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2011.10.022
de León, F. L. (2014) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(14)70712-7
Rocafort, M., & Paredes, R. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2013.09.011
Cornonary Heart Disease Risk and HIV Infection: The Roles of Inflammation and Co-Morbid Disease
So‐Armah, K. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Joseph, G. J. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Drugs of Abuse and NeuroAIDS: Opiates
Rogers, T. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1071-7_22
Trevillyan, J. M., & Hoy, J. (2014) · Microbiology Australia · doi:10.1071/ma14027
Treating HIV and African ethnicity : towards chronic care
Schoffelen, A. F. (2015) · Utrecht University Repository (Utrecht University)
The influence of host genetic factors on HIV-1 infection
van Manen, D. (2011) · UvA-DARE (University of Amsterdam)
Racial Comparison of D-Dimer Levels in Adults Before and After HIV Infection
O’Bryan, T. A., Freiberg, M. S., Tracy, R. P., So‐Armah, K., Okulicz, J. F., Ganesan, A., Lalani, T., Armstrong, A. W., Rimland, D., Deiss, R., et al. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv133.1206
Self-citationThe Fatty Acids-Inflammation Relationship Across The Lifecycle
Wang, H. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)
Petrilli, A. A. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2015.tde-21082015-135240
Inflammatory Markers Remain Elevated in HIV Infection
Zuger, A. (2010) · Journal watch · doi:10.1056/ac201006070000002
Cogliandro, V., Gazzola, L., Iannotti, N., Savoldi, A., Bini, T., & Monforte, A. D. (2016) · JHA - Journal of HIV and Ageing · doi:10.19198/jha31403
Lladó, L. I. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
HIV infection and hypertension: Epidemiological and pathogenetic aspects
Manner, I. W. (2013) · NORA - Norwegian Open Research Archives
Bermúdez, E., & Patricia, J. (2015) · TDX (Tesis Doctorals en Xarxa)
Zanetti, H. R. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.13140/rg.2.2.22633.70247
Towards a Cure: HIV Reservoirs and Strategies to control them
Schrijvers, R., Rijck, J. D., Gijsbers, R., Ronen, K., Bushman, K., & Debyser, Z. (2010)
สาขาวชาโรคตดเชอ ภาควชาอายรศาสตร คณะแพทยศาสตร มหาวทยาลยธรรมศาสตร
Khawcharoenporn, T. (2015)
Pashikanti, S. (2014) · KU ScholarWorks (The University of Kansas)
Drozd, D. R. (2015) · ResearchWorks at the University of Washington (University of Washington)
Brunt, S. J. (2016) · UWA Profiles and Research Repository (University of Western Australia)
Sachdev, V., Solomon, M. A., & Masur, H. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201711-2271ed
de Lima, L. J. G. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2014.tde-15052014-112509
Du, L., Lin, Y., Wang, M., Yan, L., Bai, L., Feng, P., & Tang, H. (2019) · Future Virology · doi:10.2217/fvl-2019-0005
Черешнев, В. А., Сайдакова, Е. В., Korolevskaya, L. B., Геннадьевна, Ш. Н., & Владимирович, Ш. К. (2019) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2019-1-247-256
Huber, A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/c1ea-p086
A Case Series of Therapeutic Outcomes of Head and Neck Cancer Patients with Unnoticed HIV Infection
Giotakis, A. Ι. (2019) · Journal of Cancer Research and Therapeutic Oncology · doi:10.17303/jcrto.2018.6.101
VIII. Metabolic Complications in People Living with HIV
Taniguchi, T. (2019) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.108.715
Akhidue, D. O., Akhidue, K., Alikor, C., & Ejele, O. A. (2020) · Saudi Journal of Pathology and Microbiology · doi:10.36348/sjpm.2020.v05i03.005
Avaliação de imunossenescência precoce em pacientes com imunodeficiência comum variável (ICV)
Coutinho, É. M. M. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2020.tde-03072020-150741
Tunggal, H. C., Munson, P. V., O’Connor, M. A., Hajari, N., Dross, S., Bratt, D., Fuller, J. T., Bagley, K., & FULLER, D. H. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.16.299511
Heart Failure and Human Immunodeficiency Virus
Bloomfield, G. S., Feinstein, M. J., & Longenecker, C. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00030-2
The features of HIV and SARS-CoV-2-coinfection in a pandemic
Фаридовна, О. А., Revathy, C. G., & Хайруллаевич, Ф. В. (2021) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2021.004
Osobennosti techeniya sochetannoj infekcii VICH/SARS-CoV-2 v usloviyah pandemii
Олейник, А. Ф., Revathy, C. G., & Хайруллаевич, Ф. В. (2021) · Вестник Российского государственного медицинского университета · doi:10.24075/vrgmu.2021.004
Microbiota Modulation to Reduce Cardiovascular Risk in HIV Patients: A Systematic ReviewPreprint
Villoslada-Blanco, P., Pérez‐Matute, P., & Oteo José, A. (2021) · Research Square · doi:10.21203/rs.3.rs-172182/v1
The Impact of Herpes Therapy on Genital and Systemic immunology
Yi, T. J. (2013) · TSpace (University of Toronto)
The Power and Wisdom of Prevention. Cardiovascular Risk, New Challenge and Approach to PLWH
Massmann, R. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.36.005808
ENERGY DISTRIBUTION OF SHOCKS CREATED BY PARTICLES DISPLACED BY IRRADIATION INSIDE AN ALLOY.
Joyes, P. (1967) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
HEFFICON: HIV Effectiveness Italian Conference.
Antinori, A., Andreoni, M., Perno, C. F., & Lazzarin, A. (2015) · PubMed
Enhancing T-cell responses to vaccination of HIV-1 infected subjects on antiretroviral therapy
Ramirez, L. (2014) · ScholarlyCommons (University of Pennsylvania)
Features of HIV and SARS-CoV-2 coinfection in a pandemic
(2021) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2021-01
Eron, J., & Hurt, C. B. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717962173.793466313
(2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328347b40e
Wang, Y. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718145474.793487579
Bailin, S. S., Kropski, J. A., Gangula, R., Hannah, L., Simmons, J. D., Mashayekhi, M., Ye, F., Fan, R., Mallal, S. A., Warren, C. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.21.484794
Elbim, C., & Appay, V. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_81
Cardiovascular Disease, Metabolic Complications and Lipodystrophy in Persons with HIV
Pereira, L. F., Goforth, H. W., Martínez, E., Lux, J. Z., Ferrara, M., & Mullen, M. P. (2017) · doi:10.1093/med/9780199392742.003.0046
Fasano, A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736111092.793570063
Elbim, C., & Appay, V. (2013) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_81-2
Overview of HIV-Associated Multimorbidities
Pereira, L. F., Bradley, M., Goforth, H. W., Alfonso, C. A., Lux, J. Z., Martínez, E., & Mullen, M. P. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780199392742.003.0047
Osobennosti techeniya sochetannoj infekcii VICH/SARS-CoV-2 v usloviyah pandemii
(2021) · Вестник Российского государственного медицинского университета · doi:10.24075/vrgmu.2021-01
Metadata
- Authors
- Neuhaus, J., Jacobs, Jr., Baker, J. V., Calmy, A., Duprez, D., La Rosa, A., Kuller, L. H., Pett, S. L., Ristola, M., Ross, M. J., Shlipak, M. G., Tracy, R., & Neaton, J. D.
- Affiliations
- University of Minnesota (US)
- University of Geneva (CH)
- University of Pittsburgh (US)
- UNSW Sydney (AU)
- University of Helsinki (FI)
- Icahn School of Medicine at Mount Sinai (US)
- University of California, San Francisco (US)
- University of Vermont (US)
- Corresponding author
- Neuhaus, Jacqueline
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-06-15
- Volume
- 201
- Issue
- 12
- Pages
- 1788-1795
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC2872049
- OpenAlex
- W2127517680
- Cited by
- 869
- References
- 33
- Citations by year
- 2026: 29 · 2025: 25 · 2024: 30 · 2023: 50 · 2022: 59 · 2021: 49 · 2020: 60 · 2019: 54 · 2018: 53 · 2017: 66 · 2016: 58 · 2015: 65 · 2014: 68 · 2013: 67 · 2012: 69
- FWCI
- 61.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Archive ouverte UNIGE (University of Geneva) (acceptedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (n01hc95095-66-0-1, n01hc95164-17-0-1, n01hc48050-59-0-1, n01hc48048-58-0-1, n01hc95165-34-0-1, n01hc48047-55-0-1, n01hc95161-24-0-1, n01hc095169-003, n01hc95166-21-0-1, n01hc48049-61-0-1, n01hc95162-31-0-1, n01hc95168-27-0-1, n01hc95160-18-0-1, n01hc095167-000, N01-HC- 95159, n01hc95163-22-0-1, n01hc95159-40-0-1, N01‐HC‐95169)
- National Heart, Lung, and Blood Institute (N01HC48050, N01 HC-95159, N01-HC095169, N01-HC-095165, N01 HC 95095, N01 HC095163, N01 HC048048, N01-HC-048049, N01-HC-095159, N01 HC095168, NO1-HC-48049, N01-HC-095162, N01 HC095095, N01-HC-095161, N01 HC048050, N01-HC48048, N01 HC095167, N01-HC-48-049, N01-HC-095160, N01 HC095166, N01 HC095164, N01 HC048047, NO1-HC-95095, N01-HC-480-47, N01 HC95169)
- National Institute of Allergy and Infectious Diseases (U01 AI46362, U01AI046362, U01AI042170)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK078510)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- HIV infection, inflammatory markers, coagulation markers, renal function, high-sensitivity C-reactive protein, interleukin-6, D-dimer, cystatin C, antiretroviral therapy, viral suppression, immune activation, cardiovascular risk
- MeSH terms
- Adult, Aged, Blood Coagulation Disorders, C-Reactive Protein, Female, Fibrin Fibrinogen Degradation Products, Humans, Inflammation, Kidney Diseases, Male, Middle Aged, Biomarkers, HIV Infections, Interleukin-6, Anti-HIV Agents, Viral Load, Cystatin C
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review